Showing results (1-10 of 166) with videos related to
Sort By:
Pageof 17
Journal of Cardiovascular Pharmacology|September 1, 1993
Long-term treatment (2 years) with the HMG CoA reductase inhibitors lovastatin or pravastatin in combination with cholestyramine in patients with severe primary hypercholesterolemiaB G Jacob, W O Richter, P SchwandtThe Clinical Investigator|November 1, 1993
Therapy of severe familial heterozygous hypercholesterolemia by low-density lipoprotein apheresis with immunoadsorption: effects of the addition of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors to therapyB G Jacob, W O Richter, P SchwandtRegulatory Peptides|July 30, 1990
Insulin inhibits lipolytic activity and degradation of beta-lipotropin in rabbit adipose tissueW O Richter, B G Jacob, P SchwandtMolecular and Cellular Endocrinology|July 9, 1990
Processing of the lipid-mobilizing peptide beta-lipotropin in rabbit adipose tissueW O Richter, B G Jacob, P SchwandtFortschritte Der Medizin|March 20, 1993
[Effect of three antihypertensive drug groups on lipid metabolism. Effects of alpha receptor blockers, central sympatholytic drugs and vasodilators]B G Jacob, W O Richter, P SchwandtInternational Journal of Tissue Reactions|January 1, 1991
Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteinsW O Richter, B G Jacob, P SchwandtEuropean Journal of Clinical Pharmacology|January 1, 1992
Short- and long-term effects of lovastatin and pravastatin alone and in combination with cholestyramine on serum lipids, lipoproteins and apolipoproteins in primary hypercholesterolaemiaB G Jacob, W Möhrle, W O Richter, et al.Metabolism: Clinical and Experimental|October 1, 1992
Treatment of primary chylomicronemia due to familial hypertriglyceridemia by omega-3 fatty acidsW O Richter, B G Jacob, M M Ritter, et al.Metabolism: Clinical and Experimental|July 1, 1993
Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodiesW O Richter, B G Jacob, M M Ritter, et al.Pageof 17